cetylpyridinium chloride anhydrous has been researched along with Growth Disorders in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (31.25) | 18.7374 |
| 1990's | 18 (56.25) | 18.2507 |
| 2000's | 1 (3.13) | 29.6817 |
| 2010's | 2 (6.25) | 24.3611 |
| 2020's | 1 (3.13) | 2.80 |
| Authors | Studies |
|---|---|
| Dadi, AF; Tamrat, A; Yeshaw, Y | 1 |
| Becker, AS; Davidov, AS; Eyal, O; Israeli, G; Oren, A; Weintrob, N | 1 |
| Abmann, C; Anisimova, A; Camara, AD; El-Shabrawi, MH; Elhusseini, MA; Godina, EZ; Gomula, A; Groth, D; Hassan, M; Hermanussen, M; Koziel, S; Lieberman, LS; Meigen, C; Mumm, R; Nariyama, K; Novokmet, N; Nowak-Szczepanska, N; Satake, T; Scheffler, C; Soderhall, J; Suchomlinov, A; Tutkuviene, J; Van Buuren, S; Wit, JM; Witwer-Backofen, U; Yestrebsky, CL | 1 |
| Cohen, P; Monzavi, R | 1 |
| Benjamin, M; Muyskens, J; Saenger, P | 1 |
| Jaffee, WL | 1 |
| Christiansen, JS; Jørgensen, JO | 1 |
| Brook, CG | 2 |
| Kin, CA | 1 |
| Stone, R | 1 |
| Shapiro, MH | 1 |
| Fost, N | 1 |
| Werth, B | 1 |
| Weiss, R | 1 |
| Kolata, G | 1 |
| Saul, H | 1 |
| Anderson, I | 1 |
| Murray, T | 1 |
| Miller, SK | 1 |
| Rothman, DJ | 1 |
| Kiernan, V | 1 |
| Tauer, CA | 1 |
| Berezhkov, LF | 1 |
| Kosheleva, NG | 1 |
| Diekema, DS | 1 |
| Rieser, PA; Underwood, LE | 1 |
| Cuttler, L; Lantos, J; Siegler, M | 1 |
| Adamson, EA; Bundru, W; el Suni, A; Kaku, M; Maughan, TS; Woodruff, AW | 1 |
| Dorozhnova, KP | 1 |
5 review(s) available for cetylpyridinium chloride anhydrous and Growth Disorders
| Article | Year |
|---|---|
IGFs and IGFBPs: role in health and disease.
Topics: Animals; Diabetes Mellitus; Growth Disorders; Health; Humans; Insulin-Like Growth Factor Binding Proteins; Neoplasms; Somatomedins | 2002 |
[State of health and the subsequent development of infants born of women who have had a threatened abortion].
Topics: Abortion, Threatened; Birth Weight; Cerebral Palsy; Congenital Abnormalities; Female; Fetal Diseases; Growth; Growth Disorders; Health; Humans; Infant, Newborn; Infant, Premature; Intellectual Disability; Nervous System Diseases; Pregnancy; Risk; Vision Disorders | 1979 |
Is taller really better? Growth hormone therapy in short children.
Topics: Body Height; Child; Growth Disorders; Growth Hormone; Health; Humans; Moral Obligations; Risk Assessment; Social Responsibility; Social Values; United States | 1990 |
Is it ethical to treat healthy short children with growth hormone?
Topics: Body Height; Child; Child, Preschool; Clinical Trials as Topic; Ethics, Medical; Growth Disorders; Growth Hormone; Health; Humans; Parental Consent; Patient Selection; Resource Allocation; Risk Assessment; Self Concept; Social Perception; Uncertainty | 1989 |
Ethical issues in growth hormone therapy.
Topics: Beauty Culture; Child; Child Behavior Disorders; Culture; Ethics, Medical; Growth Disorders; Growth Hormone; Health; Humans; Patient Selection; Risk Assessment; Social Values | 1989 |
1 trial(s) available for cetylpyridinium chloride anhydrous and Growth Disorders
| Article | Year |
|---|---|
SERUM FREE CORTISOL DURING GLUCAGON STIMULATION TEST IN HEALTHY SHORT-STATURED CHILDREN AND ADOLESCENTS.
Topics: Adolescent; Adrenocorticotropic Hormone; Body Height; Child; Child, Preschool; Female; Glucagon; Growth Disorders; Health; Human Growth Hormone; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Infant; Male; Pituitary Function Tests; Pituitary-Adrenal Function Tests; Pituitary-Adrenal System | 2018 |
26 other study(ies) available for cetylpyridinium chloride anhydrous and Growth Disorders
| Article | Year |
|---|---|
Stunting and Its Associated Factors among Early Adolescent School Girls of Gondar Town, Northwest Ethiopia: A School-Based Cross-Sectional Study.
Topics: Adolescent; Child; Cross-Sectional Studies; Ethiopia; Female; Growth Disorders; Health; Humans; Logistic Models; Multivariate Analysis; Nutritional Status; Prevalence; Schools | 2020 |
"Proceedings of the 22nd Aschauer Soiree on Growth and Health Screening", held at Altenhof, Germany, November 15th, 2014.
Topics: Adolescent; Adolescent Development; Child; Child, Preschool; Germany; Growth; Growth Charts; Growth Disorders; Health; Humans; Infant; Infant, Newborn; Mass Screening; Obesity | 2015 |
Short children, anxious parents: is growth hormone the answer?
Topics: Body Height; Bone Development; Child; Ethics, Medical; Female; Genetic Diseases, Inborn; Growth Disorders; Growth Hormone; Health; Hormones; Humans; Male; Moral Obligations; Patient Selection; Pediatrics; Physician's Role; Risk Assessment; United States | 1984 |
Short stature: medical progress and ethical dilemmas.
Topics: Child; Ethics, Medical; Growth Disorders; Growth Hormone; Health; Humans; Risk Assessment | 1983 |
Little bigger, little better.
Topics: Child, Preschool; Down Syndrome; Female; Genetic Diseases, Inborn; Growth; Growth Disorders; Growth Hormone; Health; Humans; Infant; Infant, Newborn; Patient Selection; Recombinant Proteins; Risk Assessment; Therapeutic Human Experimentation; Turner Syndrome | 1994 |
Brave new senescence: GH in adults.
Topics: Adult; Aging; Growth Disorders; Growth Hormone; Health; Humans; Risk Assessment | 1993 |
Growth hormone: panacea or punishment for short stature?
Topics: Adaptation, Psychological; Body Height; Growth Disorders; Growth Hormone; Health; Humans; Patient Selection | 1997 |
Coming soon to the "genetic supermarket" near you.
Topics: Biotechnology; Body Height; Child; Drug Industry; Ethics, Medical; Federal Government; Genetic Enhancement; Genetic Therapy; Government Regulation; Growth Disorders; Health; Human Growth Hormone; Humans; Marketing of Health Services; Risk Assessment; United States; United States Food and Drug Administration | 1996 |
Growth hormone trials to contine.
Topics: Advisory Committees; Child; Federal Government; Government; Government Regulation; Growth Disorders; Health; Hormones; Human Experimentation; Humans; National Institutes of Health (U.S.); Public Policy; Research Design; Risk; Risk Assessment; Social Control, Formal; United States | 1993 |
The technology of perfection: performance enhancement and the control of attributes.
Topics: Biomedical Technology; Coercion; Dehumanization; Democracy; Ethics; Eugenics; Freedom; Genetic Engineering; Genetic Therapy; Germ Cells; Government Regulation; Growth Disorders; Health; Health Care Rationing; Hormones; Humans; Intelligence; Jurisprudence; Personal Autonomy; Pharmaceutical Preparations; Public Policy; Resource Allocation; Risk; Risk Assessment; Social Change; Social Control, Formal; Social Dominance; Social Justice; Sports Medicine; Substance-Related Disorders; Wounds and Injuries | 1991 |
"I was like -- whoa": a commentary on Shapiro's Performance enhancement and the control of attributes.
Topics: Biomedical Technology; Dehumanization; Ethics; Eugenics; Freedom; Genetic Engineering; Genetic Therapy; Growth Disorders; Health; Health Care Rationing; Hormones; Humans; Pharmaceutical Preparations; Public Policy; Resource Allocation; Risk; Risk Assessment; Social Control, Formal; Social Justice; Social Values; Sports Medicine; Value of Life | 1991 |
How short is too short?
Topics: Adolescent; Aged; Diagnosis; Drug Industry; Economics; Growth Disorders; Health; Health Care Rationing; Hormones; Human Experimentation; Human Growth Hormone; Humans; Minors; Motivation; Patient Care; Patient Selection; Research Personnel; Resource Allocation; Risk; Risk Assessment; Stress, Psychological; United States; Volunteers | 1991 |
Are short kids 'sick'
Topics: Advertising; Child; Diagnosis; Drug Industry; Economics; Federal Government; Government; Government Regulation; Growth Disorders; Health; Health Care Rationing; Hormones; Humans; Mass Screening; Patient Advocacy; Patient Care; Patient Selection; Pharmaceutical Preparations; Physicians; Prejudice; Prognosis; Risk; Risk Assessment; Social Control, Formal; United States | 1994 |
Selling growth drug for children: the legal and ethical questions.
Topics: Biomedical Research; Child; Coercion; Conflict of Interest; DNA, Recombinant; Drug Industry; Economics; Financial Support; Fraud; Growth Disorders; Health; Hormones; Human Growth Hormone; Humans; Medicaid; Parents; Patient Selection; Pharmaceutical Preparations; Physicians; Professional Misconduct; Research; Research Subjects; Statistics as Topic; Students; United States | 1994 |
Can we grow younger?
Topics: Aged; Growth Disorders; Health; Hormones; Human Experimentation; Humans; Life Expectancy; Risk; Risk Assessment | 1994 |
Walk tall--with a synthetic growth hormone.
Topics: Child; DNA, Recombinant; Growth Disorders; Health; Hormones; Human Experimentation; Humans; Patient Care; Pharmaceutical Preparations; Risk; Risk Assessment | 1983 |
The growing danger from gene-spliced hormones.
Topics: Child; DNA, Recombinant; Genetic Therapy; Growth Disorders; Health; Hormones; Humans; Parents; Patient Care; Prejudice; Risk; Risk Assessment; Social Justice; Socioeconomic Factors; Stress, Psychological | 1987 |
Ethics lobby forces rethink on growth hormones.
Topics: Child; Chromosome Aberrations; Chromosome Disorders; Control Groups; DNA, Recombinant; Ethical Review; Ethics; Ethics Committees; Ethics Committees, Research; Federal Government; Government; Government Regulation; Growth Disorders; Health; Hormones; Human Experimentation; Humans; Jurisprudence; National Institutes of Health (U.S.); Nontherapeutic Human Experimentation; Patient Care; Pharmaceutical Preparations; Placebos; Politics; Research Design; Risk; Risk Assessment; Social Control, Formal; Turner Syndrome; United States | 1992 |
Shiny, happy people: the problem with "cosmetic psychopharmacology.
Topics: Behavior; Behavior Control; Depressive Disorder; Female; Fluoxetine; Genetic Determinism; Genetic Engineering; Genetic Enhancement; Genetics, Behavioral; Growth Disorders; Health; Hormones; Humans; Men; Mental Disorders; Mental Health; Physicians; Psychiatry; Psychotherapy; Psychotropic Drugs; Quality of Life; Risk; Risk Assessment; Self Concept; Social Change; Social Control, Formal; Surgery, Plastic; United States; Women | 1994 |
Doctor charged over growth hormone payments.
Topics: Child; Conflict of Interest; Drug Industry; Federal Government; Fees and Charges; Financial Support; Government; Government Regulation; Growth Disorders; Health; Hormones; Human Growth Hormone; Humans; Mass Screening; Minnesota; Patient Care; Physicians; Professional Misconduct; Social Control, Formal; Students; United States; United States Food and Drug Administration | 1994 |
The NIH trials of growth hormone for short stature.
Topics: Advisory Committees; Child; DNA, Recombinant; Ethical Review; Ethics; Eugenics; Federal Government; Government; Government Regulation; Growth Disorders; Health; Hormones; Human Experimentation; Humans; Informed Consent; National Institutes of Health (U.S.); Placebos; Public Policy; Research Design; Risk; Risk Assessment; Social Control, Formal; United States | 1994 |
[Pressing problems of the health status of schoolchildren].
Topics: Adolescent; Child; Child, Preschool; Female; Growth; Growth Disorders; Health; Health Status; Humans; Male; Obesity; Sexual Maturation; Thinness; Tonsillitis | 1979 |
Who's for growth hormone?
Topics: Child; Growth; Growth Disorders; Growth Hormone; Health; Humans; Patient Selection; Resource Allocation; Risk Assessment; Therapeutic Human Experimentation | 1992 |
How far should indications for growth hormone treatment expand?
Topics: Body Height; Female; Growth Disorders; Growth Hormone; Health; Humans; Patient Selection; Risk Assessment; Risk Factors | 1990 |
Children in Juba, southern Sudan: the second and third years of life.
Topics: Body Height; Body Weight; Child, Preschool; Chronic Disease; Failure to Thrive; Female; Growth Disorders; Health; Health Education; Health Status; Hepatitis B; Humans; Infant; Infant Mortality; Male; Prospective Studies; Protein-Energy Malnutrition; Skull; Sudan | 1986 |
[Urgent problems in the physical development of children and adolescents].
Topics: Adolescent; Body Constitution; Child; Growth; Growth Disorders; Health; Humans | 1974 |